Skip to main content
2024 ACRM Annual Fall Conference & EXPO Main banner
G4 Foot Drop System
REGISTER NOW
REGISTER NOW
Final Program


AT-A-GLANCE PDF
Back
Register Now

LaunchPad (A Rehabilitation Technology Innovation Competition)

Technology

Neurawear: Wearable brain-computer interface for stroke rehabilitation anywhere 2280

Thursday, October 31, 2024
2:41 PM – 2:49 PM  
Location:  ROOM: Topaz REGION: Tower Lobby Level >>> DIRECTIONS: From ACRM Registration desk, face the elephants and turn left. The Topaz is the first room on the left, across from the Elephants.
The presentation will focus on Neurawear, a cutting-edge wearable neurotechnology designed to transform stroke rehabilitation. We will highlight how our patented hydrogel electrodes and wearable headset provide continuous, at-home BCI-FES stroke rehabilitation therapy, making rehabilitation more accessible and effective for stroke patients. By integrating advanced EEG technology with long-term usability, Neurawear is poised to fill a critical gap in stroke recovery, offering a cost-effective solution for patients. The presentation will showcase our journey, the technology behind Neurawear, and its potential to advance stroke rehabilitation with an on-the-go format.

Learning Objectives:

  • explain the current critical gaps in stroke rehabilitation, including the limitations of existing solutions, and identify how Neurawear’s on-the-go format addresses these challenges to enhance patient outcomes.
  • describe the technology behind Neurawear, including its patented hydrogel electrodes and BCI-FES system, and how it enables continuous, at-home stroke rehabilitation.
  • explain the benefits of Neurawear’s wearable neurotechnology in improving accessibility and effectiveness for stroke rehabilitation patients.
  • describe Neurawear’s go-to-market strategy, highlighting how the product will be positioned to address these challenges and reach the target market effectively.
Disclosure(s):
Ilya Pyatnitskiy, MD: Neurawear: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)